Ignite Creation Date:
2024-05-06 @ 5:52 PM
Last Modification Date:
2024-10-26 @ 2:37 PM
Study NCT ID:
NCT05466149
Status:
RECRUITING
Last Update Posted:
2023-02-01
First Post:
2022-07-14
Brief Title:
Efficacy and Safety of Furmonertinib in Patients With Locally Advanced or Metastatic NSCLC With EGFR Exon 20 Insertion
Sponsor:
Organization:
Allist Pharmaceuticals Inc